Infect Chemother.  2014 Jun;46(2):125-138. 10.3947/ic.2014.46.2.125.

Clinical Guidelines for the Antimicrobial Treatment of Bone and Joint Infections in Korea

• The Korean Society for Chemotherapy
• The Korean Society of Infectious Diseases
• The Korean Orthopaedic Association

• KMID: 2284991
• DOI: http://doi.org/10.3947/ic.2014.46.2.125

Abstract

There are many various diseases in the bone and joint infections, and we tried to make antimicrobial treatment guidelines for common infectious diseases based on available data for microbiology and clinical trials. This guidelines focused on the treatment of osteomyelitis and septic arthritis, which can be experienced by physicians at diverse clinical settings. This guidelines is not applicable to diabetic foot infections, postoperative infections or post-traumatic infections which need special considerations. The guidelines for those conditions will be separately developed later. Surgical treatment of bone and joint infections, pediatric bone and joint infection, tuberculous bone and joint infection, and prophylactic antibiotic use were not included in this guideline.

Keyword

Osteomyelitis; Septic arthritis; Antimicrobial treatment

MeSH Terms

Arthritis, Infectious
Communicable Diseases
Diabetic Foot
Joints*
Korea
Osteomyelitis

Figure

• 

  Figure 1 Cierny-Mader classification of osteomyelitis according to the anatomical extent.

• 

  Figure 2 Treatment algorithm for adult long bone osteomyelitis (Figures modified from Lazzarini et al. [10] Reprinted with permission from The Journal of Bone and Joint Surgery).

Reference

1. Carek PJ, Dickerson LM, Sack JL. Diagnosis and management of osteomyelitis. Am Fam Physician. 2001; 63:2413–2420.

2. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med. 1970; 282:198–206.

3. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004; 364:369–379.

4. Cierny G, Mader JT, Pennick JJ. A clinical staging system for adult osteomyelitis. Contemp Orthop. 1985; 10:17–37.

5. Esposito S, Leone S, Bassetti M, Borrè S, Leoncini F, Meani E, Venditti M, Mazzotta F. Bone Joint Infections Committee for the Italian Society of Infectious Tropical Diseases (SIMIT). Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults. Infection. 2009; 37:478–496.

6. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997; 336:999–1007.

7. Kim CJ, Song KH, Park WB, Kim ES, Park SW, Kim HB, Oh MD, Kim NJ. Microbiologically and clinically diagnosed vertebral osteomyelitis: impact of prior antibiotic exposure. Antimicrob Agents Chemother. 2012; 56:2122–2124.

8. Kim YI, Kim SE, Jang HC, Jung SI, Song SK, Park KH. Analysis of the clinical characteristics and prognostic factors of infectious spondylitis. Infect Chemother. 2011; 43:48–54.

9. Dirschl DR, Almekinders LC. Osteomyelitis. Common causes and treatment recommendations. Drugs. 1993; 45:29–43.

10. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am. 2004; 86-A:2305–2318.

11. Weston V, Coakley G. British Society for Rheumatology (BSR) Standards, Guidelines and Audit Working Group. British Society for Antimicrobial Chemotherapy. British Orthopaedic Association. Royal College of General Practitioners. British Health Professionals in Rheumatology. Guideline for the management of the hot swollen joint in adults with a particular focus on septic arthritis. J Antimicrob Chemother. 2006; 58:492–493.

12. Coakley G, Mathews C, Field M, Jones A, Kingsley G, Walker D, Phillips M, Bradish C, McLachlan A, Mohammed R, Weston V. British Society for Rheumatology Standards, Guidelines and Audit Working Group. BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology (Oxford). 2006; 45:1039–1041.

13. Brook I, Frazier EH. Anaerobic osteomyelitis and arthritis in a military hospital: a 10-year experience. Am J Med. 1993; 94:21–28.

14. Euba G, Murillo O, Fernández-Sabé N, Mascaró J, Cabo J, Pérez A, Tubau F, Verdaguer R, Gudiol F, Ariza J. Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis. Antimicrob Agents Chemother. 2009; 53:2672–2676.

15. Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology (Oxford). 2001; 40:24–30.

16. Ispahani P, Weston VC, Turner DP, Donald FE. Septic arthritis due to Streptococcus pneumoniae in Nottingham, United Kingdom, 1985-1998. Clin Infect Dis. 1999; 29:1450–1454.

17. Rhee YG, Cho NS, Kim BH, Ha JH. Injection-induced pyogenic arthritis of the shoulder joint. J Shoulder Elbow Surg. 2008; 17:63–67.

18. Saraux A, Taelman H, Blanche P, Batungwanayo J, Clerinx J, Kagame A, Kabagabo L, Ladner J, Van de Perre P, Le Goff P, Bogaerts J. HIV infection as a risk factor for septic arthritis. Br J Rheumatol. 1997; 36:333–337.

19. Seo SS, Ha DJ, Kim CW, Kim KW, Seo JH. Etiologic transition of septic arthritis of the knee. J Korean Knee Soc. 2008; 20:44–49.

20. Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991. Ann Rheum Dis. 1999; 58:214–219.

21. Dubost JJ, Soubrier M, De Champs C, Ristori JM, Bussiére JL, Sauvezie B. No changes in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann Rheum Dis. 2002; 61:267–269.

22. Arnold SR, Elias D, Buckingham SC, Thomas ED, Novais E, Arkader A, Howard C. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop. 2006; 26:703–708.

23. Millar BC, Loughrey A, Elborn JS, Moore JE. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect. 2007; 67:109–113.

24. Kim ES, Song JS, Lee HJ, Choe PG, Park KH, Cho JH, Park WB, Kim SH, Bang JH, Kim DM, Park KU, Shin S, Lee MS, Choi HJ, Kim NJ, Kim EC, Oh MD, Kim HB, Choe KW. A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. J Antimicrob Chemother. 2007; 60:1108–1114.

25. Chen WH, Jiang LS, Dai LY. Surgical treatment of pyogenic vertebral osteomyelitis with spinal instrumentation. Eur Spine J. 2007; 16:1307–1316.

26. Walker DJ, Young I, Hassey GA, Smith AM, Goring M, Platt PN. The acute hot joint in medical practice. J R Coll Physicians Lond. 1995; 29:101–104.

27. Kim H, Kim J, Ihm C. The usefulness of multiplex PCR for the identification of bacteria in joint infection. J Clin Lab Anal. 2010; 24:175–181.

28. Cooke CL, Owen DS Jr, Irby R, Toone E. Gonococcal arthritis. A survey of 54 cases. JAMA. 1971; 217:204–205.

29. Rompalo AM, Hook EW 3rd, Roberts PL, Ramsey PG, Handsfield HH, Holmes KK. The acute arthritis-dermatitis syndrome. The changing importance of Neisseria gonorrhoeae and Neisseria meningitidis. Arch Intern Med. 1987; 147:281–283.

30. Wise CM, Morris CR, Wasilauskas BL, Salzer WL. Gonococcal arthritis in an era of increasing penicillin resistance. Presentations and outcomes in 41 recent cases (1985-1991). Arch Intern Med. 1994; 154:2690–2695.

31. Carragee EJ, Kim D, van der Vlugt T, Vittum D. The clinical use of erythrocyte sedimentation rate in pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976). 1997; 22:2089–2093.

32. Kaandorp CJ, Van Schaardenburg D, Krijnen P, Habbema JD, van de Laar MA. Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum. 1995; 38:1819–1825.

33. Eberst-Ledoux J, Tournadre A, Mathieu S, Mrozek N, Soubrier M, Dubost JJ. Septic arthritis with negative bacteriological findings in adult native joints: a retrospective study of 74 cases. Joint Bone Spine. 2012; 79:156–159.

34. Gupta MN, Sturrock RD, Field M. Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis. Ann Rheum Dis. 2003; 62:327–331.

35. Jeng GW, Wang CR, Liu ST, Su CC, Tsai RT, Yeh TS, Wen CL, Wu YQ, Lin CY, Lee GL, Chen MY, Liu MF, Chuang CY, Chen CY. Measurement of synovial tumor necrosis factor-alpha in diagnosing emergency patients with bacterial arthritis. Am J Emerg Med. 1997; 15:626–629.

36. Shmerling RH, Delbanco TL, Tosteson AN, Trentham DE. Synovial fluid tests. What should be ordered? JAMA. 1990; 264:1009–1014.

37. Margaretten ME, Kohlwes J, Moore D, Bent S. Does this adult patient have septic arthritis? JAMA. 2007; 297:1478–1488.